KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Debt to Equity (2019 - 2025)

Historic Debt to Equity for Evolent Health (EVH) over the last 7 years, with Q3 2025 value amounting to $1.26.

  • Evolent Health's Debt to Equity rose 11798.27% to $1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.26, marking a year-over-year increase of 11798.27%. This contributed to the annual value of $0.66 for FY2024, which is 1823.41% up from last year.
  • Per Evolent Health's latest filing, its Debt to Equity stood at $1.26 for Q3 2025, which was up 11798.27% from $0.92 recorded in Q2 2025.
  • Evolent Health's Debt to Equity's 5-year high stood at $1.26 during Q3 2025, with a 5-year trough of $0.31 in Q4 2021.
  • Its 5-year average for Debt to Equity is $0.58, with a median of $0.56 in 2023.
  • Its Debt to Equity has fluctuated over the past 5 years, first crashed by 3354.38% in 2021, then surged by 11798.27% in 2025.
  • Quarter analysis of 5 years shows Evolent Health's Debt to Equity stood at $0.31 in 2021, then surged by 54.55% to $0.48 in 2022, then increased by 16.37% to $0.56 in 2023, then grew by 18.23% to $0.66 in 2024, then surged by 90.35% to $1.26 in 2025.
  • Its Debt to Equity stands at $1.26 for Q3 2025, versus $0.92 for Q2 2025 and $0.88 for Q1 2025.